(Q37165503)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Pharmacological management of atypical antipsychotic-induced weight gain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Trino Baptista

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Yamily ElFakih

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Euderruh Uzcátegui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Eduardo Tálamo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Enma Araujo de Baptista

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Serge Beaulieu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

477-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18484791%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00023210-200822060-00003

7 January 2020

exact match

0 references

cites work

Weight gain associated with neuroleptic medication: a review

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822060-00003

Biological perspectives. Aripiprazole: a third generation of antipsychotics begins?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822060-00003

Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822060-00003

Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200822060-00003

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

21 January 2018

1 reference

12 December 2020

Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection

1 reference

12 December 2020

Gender differences in the prescribing of antipsychotic drugs

1 reference

12 December 2020

Clinical experience with Topiramate to counteract neuroleptic induced weight gain in 10 individuals with autistic spectrum disorders

1 reference

12 December 2020

Orlistat in the treatment of clozapine-induced hyperglycemia and weight gain

1 reference

12 December 2020

[Antipsychotic-induced weight gain--pharmacogenetic studies]

1 reference

12 December 2020

Association of initial antipsychotic response to clozapine and long-term weight gain

1 reference

12 December 2020

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study

1 reference

12 December 2020

Quetiapine lowers sympathetic and hyperthermic reactions due to cerebral injection of orexin A.

1 reference

12 December 2020

Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine

1 reference

12 December 2020

Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.

1 reference

12 December 2020

Effect of amantadine on weight gain during olanzapine treatment

1 reference

12 December 2020

Association of olanzapine-induced weight gain with an increase in body fat.

1 reference

12 December 2020

Antipsychotic drugs and reproductive hormones: relationship to body weight regulation

1 reference

12 December 2020

Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics

1 reference

12 December 2020

Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin

1 reference

12 December 2020

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

1 reference

12 December 2020

Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs

1 reference

12 December 2020

The association of weight gain and olanzapine plasma concentrations.

1 reference

12 December 2020

Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease

1 reference

12 December 2020

Current and potential drugs for treatment of obesity

1 reference

12 December 2020

Clinical pharmacodynamics and pharmacokinetics of antimanic and mood-stabilizing medications

1 reference

12 December 2020

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

1 reference

12 December 2020

Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate

1 reference

12 December 2020

Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

1 reference

12 December 2020

Serum ghrelin concentrations in patients receiving olanzapine or risperidone

1 reference

12 December 2020

Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus

1 reference

12 December 2020

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study

1 reference

12 December 2020

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain.

1 reference

12 December 2020

Drug-induced weight gain

1 reference

12 December 2020

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

1 reference

12 December 2020

The serotonin syndrome

1 reference

12 December 2020

The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study

1 reference

12 December 2020

Is clozapine antisuicidal?

1 reference

12 December 2020

Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia

1 reference

12 December 2020

Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.

1 reference

12 December 2020

Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes

1 reference

12 December 2020

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

1 reference

12 December 2020

Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia

1 reference

12 December 2020

Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.

1 reference

12 December 2020

Hypothalamic dopamine and serotonin in the regulation of food intake.

1 reference

12 December 2020

Risperidone-associated weight gain in children and adolescents: a retrospective chart review

1 reference

12 December 2020

Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine

1 reference

12 December 2020

Atypical antipsychotics and weight gain--a systematic review

1 reference

12 December 2020

A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.

1 reference

12 December 2020

Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis

1 reference

12 December 2020

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances

1 reference

12 December 2020

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis

1 reference

12 December 2020

Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study

1 reference

12 December 2020

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents

1 reference

12 December 2020

[Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment]

1 reference

12 December 2020

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

1 reference

12 December 2020

Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.

1 reference

12 December 2020

Energy expenditure and physical activity in clozapine use: implications for weight management

1 reference

12 December 2020

Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients

1 reference

12 December 2020

A case series describing orlistat use in patients on psychotropic medications

1 reference

12 December 2020

Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.

1 reference

12 December 2020

Antipsychotic drugs and obesity: is prolactin involved?

1 reference

12 December 2020

Clozapine weight gain, plus topiramate weight loss

1 reference

12 December 2020

A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions.

1 reference

12 December 2020

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

Weight gain from novel antipsychotic drugs: need for action

1 reference

12 December 2020

Treatment of the metabolic disturbances caused by antipsychotic drugs: focus on potential drug interactions

1 reference

12 December 2020

Energy balance and reproduction

1 reference

12 December 2020

Clinically significant drug interactions with antidepressants in the elderly.

1 reference

12 December 2020

The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients

1 reference

12 December 2020

Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics

1 reference

12 December 2020

Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

1 reference

12 December 2020

1 reference

12 December 2020

Randomized, open label study on the use of ranitidine at different doses for the management of weight gain associated with olanzapine administration

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Orlistat in the treatment of psychopharmacologically induced weight gain.

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

1 reference

12 December 2020

Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: a pilot study

1 reference

12 December 2020

Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients

1 reference

12 December 2020

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

12 December 2020

H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients

1 reference

12 December 2020

Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study

1 reference

12 December 2020

Topiramate as an adjuvant treatment with atypical antipsychotics in schizophrenic patients experiencing weight gain

1 reference

12 December 2020

Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients.

1 reference

12 December 2020

Metformin for weight loss in pediatric patients taking psychotropic drugs

1 reference

12 December 2020

Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia

1 reference

12 December 2020

Olanzapine increases plasma ghrelin level in patients with schizophrenia

1 reference

12 December 2020

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats

1 reference

12 December 2020

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

1 reference

12 December 2020

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

1 reference

12 December 2020

Clozapine blocks sympathetic and thermogenic reactions induced by orexin A in rat

1 reference

12 December 2020

1 reference

12 December 2020

Antipsychotic drug-induced weight gain: development of an animal model

1 reference

12 December 2020

Amantadine for weight gain associated with olanzapine treatment

1 reference

12 December 2020

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

12 December 2020

Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora

1 reference

12 December 2020

Open label study of the effect of amantadine on weight gain induced by olanzapine

1 reference

12 December 2020

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial

1 reference

12 December 2020

Longitudinal evaluation of reproductive function in women treated for bipolar disorder

1 reference

12 December 2020

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

12 December 2020

Effect of Topiramate on Plasma Concentrations of Clozapine, Olanzapine, Risperidone, and Quetiapine in Patients With Psychotic Disorders

1 reference

12 December 2020

Bodyweight gain with atypical antipsychotics. A comparative review

1 reference

12 December 2020

Antidepressants and the serotonin syndrome in general practice

1 reference

12 December 2020

Review of quetiapine and its clinical applications in schizophrenia

1 reference

12 December 2020

Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study

1 reference

12 December 2020

Nizatidine for the treatment of patients with quetiapine-induced weight gain

1 reference

12 December 2020

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

1 reference

12 December 2020

Topiramate for reversing atypical antipsychotic weight gain

1 reference

12 December 2020

Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study.

1 reference

12 December 2020

Gonadal steroids and energy homeostasis in the leptin era.

1 reference

12 December 2020

Correlation of serum ghrelin levels with body mass index and carbohydrate metabolism in patients treated with atypical antipsychotics.

1 reference

12 December 2020

Resting energy expenditure is lower than predicted in people taking atypical antipsychotic medication

1 reference

12 December 2020

Interventions to reduce weight gain in schizophrenia

1 reference

12 December 2020

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment.

1 reference

12 December 2020

Modulation of appetite by gonadal steroid hormones

1 reference

12 December 2020

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

1 reference

12 December 2020

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial

1 reference

12 December 2020

Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study

1 reference

12 December 2020

Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents

1 reference

12 December 2020

A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia

1 reference

12 December 2020

Experiences with large scale interhospital cooperative research in chemotherapy

1 reference

12 December 2020

Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia

1 reference

12 December 2020

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

1 reference

12 December 2020

A prospective study of serum ghrelin levels in patients treated with clozapine

1 reference

12 December 2020